Literature DB >> 16060906

Circulating acylated and total ghrelin and galanin in children with insulin-treated type 1 diabetes: relationship to insulin therapy, metabolic control and pubertal development.

F Celi1, V Bini, F Papi, E Santilli, A Ferretti, M Mencacci, M G Berioli, G De Giorgi, A Falorni.   

Abstract

OBJECTIVE: To study the circulating levels of two gut-derived peptides in children with type 1 (insulin-dependent) diabetes mellitus (IDDM). RESEARCH DESIGN AND METHODS: Plasma levels of ghrelin, both total ghrelin (TG) and the acylated form (AG), and galanin and their relationships with insulin dosage, metabolic control, IGFBP-1, body mass and pubertal development were evaluated in 91 children, aged 11.1 +/- 2.7 years, affected by IDDM and treated with insulin. Ninety-one healthy children were selected as controls.
RESULTS: Body mass index (BMI)-adjusted levels of both forms of ghrelin were reduced in IDDM compared with healthy subjects, with greater values in prepubertal than pubertal IDDM subjects. A negative association was found between AG and fasting insulin serum levels and insulin resistance [measured by using the homeostasis model assessment of insulin resistance (HOMA IR)] among the healthy children. IDDM children showed a negative association of their plasma ghrelin (both acylated and total) with daily insulin dosage, and the three adiposity indices (BMI, skinfold thickness and percentage fat mass). IGFBP-1 levels were higher among the IDDM children without any association with ghrelin serum values. BMI-adjusted plasma levels of galanin were higher among IDDM compared to healthy subjects, irrespective of sex or pubertal development. Greater values for galanin were found among pubertal than prepubertal subjects in both groups without any significant differences between the genders. A positive association was found between galanin and BMI in both groups and between galanin and haemoglobin A1c (HbA1c) among the IDDM children. No relationship existed between either galanin and fasting serum insulin among the healthy subjects or galanin and both insulin dosage or duration of treatment among the IDDM subjects.
CONCLUSIONS: The associations found between both ghrelin and galanin with adiposity indices could be considered as an indirect signal of involvement of the two peptides in the development of the nutritional status of the IDDM adolescents. The reduction in both forms of ghrelin could be involved in the development of the body mass increase of IDDM subjects with opposite effects, either influencing insulin sensitivity or exerting a compensatory restraint of feeding.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16060906     DOI: 10.1111/j.1365-2265.2005.02313.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  8 in total

Review 1.  Current and potential roles of ghrelin in clinical practice.

Authors:  G Angelidis; V Valotassiou; P Georgoulias
Journal:  J Endocrinol Invest       Date:  2010-12       Impact factor: 4.256

2.  Regulation of glucose and insulin release following acute and repeated treatment with the synthetic galanin analog NAX-5055.

Authors:  Sean P Flynn; H Steve White
Journal:  Neuropeptides       Date:  2015-01-21       Impact factor: 3.286

3.  Effects of electroacupuncture on the expression of hypothalamic neuropeptide Y and ghrelin in pubertal rats with polycystic ovary syndrome.

Authors:  Yang Li; Wang Zhi; Dong Haoxu; Wang Qing; Cheng Ling; Yi Ping; Huang Dongmei
Journal:  PLoS One       Date:  2022-06-15       Impact factor: 3.752

4.  Breast milk hormones and regulation of glucose homeostasis.

Authors:  Francesco Savino; Stefania Alfonsina Liguori; Miriam Sorrenti; Maria Francesca Fissore; Roberto Oggero
Journal:  Int J Pediatr       Date:  2011-05-05

5.  Serum Galanin Levels in Young Healthy Lean and Obese Non-Diabetic Men during an Oral Glucose Tolerance Test.

Authors:  Héctor Fabio Sandoval-Alzate; Yessica Agudelo-Zapata; Angélica María González-Clavijo; Natalia E Poveda; Cristian Felipe Espinel-Pachón; Jorge Augusto Escamilla-Castro; Heidy Lorena Márquez-Julio; Hernando Alvarado-Quintero; Fabián Guillermo Rojas-Rodríguez; Juan Manuel Arteaga-Díaz; Javier Hernando Eslava-Schmalbach; Maria Fernanda Garcés-Gutiérrez; Maria Vrontakis; Justo P Castaño; Raul M Luque; Carlos Diéguez; Rubén Nogueiras; Jorge E Caminos
Journal:  Sci Rep       Date:  2016-08-23       Impact factor: 4.379

6.  Serum nesfatin-1 and galanin concentrations in the adult with metabolic syndrome. Relationships to insulin resistance and obesity.

Authors:  Maryam N Alotibi; Amina M Alnoury; Amani M Alhozali
Journal:  Saudi Med J       Date:  2019-01       Impact factor: 1.484

Review 7.  The endocrine pancreas during exercise in people with and without type 1 diabetes: Beyond the beta-cell.

Authors:  Olivia McCarthy; Signe Schmidt; Merete Bechmann Christensen; Stephen C Bain; Kirsten Nørgaard; Richard Bracken
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-06       Impact factor: 6.055

8.  Bisphenol A Causes Liver Damage and Selectively Alters the Neurochemical Coding of Intrahepatic Parasympathetic Nerves in Juvenile Porcine Models under Physiological Conditions.

Authors:  Michael Thoene; Liliana Rytel; Ewa Dzika; Andrzej Włodarczyk; Ewa Kruminis-Kaszkiel; Ptaszyński Konrad; Joanna Wojtkiewicz
Journal:  Int J Mol Sci       Date:  2017-12-15       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.